Recent News

By Category: Research

House Panel Gives Controversial Biodefense Lab a Boost

(Science Now) A U.S. House of Representatives committee today takes up a 2013 spending bill for the Department of Homeland Security (DHS) that would partly reverse deep cuts in the agency’s science and technology programs. It also provides $75 million for a controversial agricultural biodefense laboratory in Kansas that the Obama Administration had zeroed out  Read More »

Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics

(Press Release) Foot-and-mouth disease (FMD) is the most economically important and highly contagious disease of cloven-hoofed animals worldwide. Control of the disease has been mainly based on large-scale vaccinations with whole-virus inactivated vaccines. In recent years, a series of outbreaks of type O FMD occurred in China (including Chinese Taipei, Chinese Hong Kong) posed a  Read More »

Breaking: US House Appropriations Committee Passes Funding for NBAF

(GardnerEDGE) Washington, DC – Congressman Kevin Yoder made the following statement today after the House Appropriations Committee passed the Department of Homeland Security Appropriations Bill for Fiscal Year 2013. The legislation includes $75 million for the construction of the National Bio and Agro-Defense Facility in Manhattan, KS., and received broad bipartisan support. Representative Yoder is  Read More »

Health experts narrow the hunt for Ebola – EurekAlert (press release)

Health experts narrow the hunt for EbolaEurekAlert (press release)Response efforts to outbreaks of Ebola hemorrhagic fever in Africa can benefit from a standardized sampling strategy that focuses on the carcasses of gorillas, …and more »

Phase I enrollment for A/H5N1 influenza vaccine trial begins

(Vaccine News Daily) Novavax, Inc., a Rockville, Maryland-based clinical-stage biopharmaceutical company, has started enrollment for its second phase I clinical trial for a monovalent virus-like particle vaccine candidate against A/H5N1 avian influenza viruses. The placebo-controlled, dose-ranging, observer blind, randomized trial is being conducted as part of Novavax’s contract with the Biomedical Advanced Research and Development  Read More »

« First...102030...208209210211212...220230240...Last »

Also filed under "Research":